WellDoc expands leadership team by hiring healthcare industry veteran Nick Harsh as new Vice President, Market Access
WellDoc, a digital health technology leader, announced today that healthcare industry veteran Nick Harsh has joined the company as Vice President, Market Access. In this new role, Mr. Harsh will be responsible for leading WellDoc’s payer strategy, relationships and execution.
“WellDoc is utilizing 21st century technology to partner patients and their caregivers with medical providers to deliver better healthcare outcomes,” said Mr. Harsh. “I’m excited about my new role with WellDoc, and the impact we can make on the management of type 2 diabetes and other chronic diseases.”
Over the last 15 years, Mr. Harsh been a part of the management team for the AstraZeneca organization, launching and supporting several AstraZeneca and MedImmune well-recognized brands, including Nexium, Crestor and FluMist. Most recently, he led the commercial strategy, pricing, operations, and channel distribution services for MedImmune’s specialty biologics. Mr. Harsh has spent more than 30 years in the pharmaceutical, medical device and biotech fields—in senior commercial roles leading the market access initiatives.
“Nick is a great addition to our growing WellDoc leadership team,” said Kevin McRaith, Chief Executive Officer at WellDoc. “The breadth and depth of his managed market knowledge and experience with product commercialization will allow WellDoc to expand the market presence of BlueStar and future digital health products.”